NCT03620708

Brief Summary

Randomized clinical trial comparing 3 brief interventions designed to increase motivation to quit smoking in socioeconomically disadvantaged smokers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started May 2018

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 30, 2018

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 29, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 8, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2018

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

November 15, 2019

Completed
Last Updated

November 15, 2019

Status Verified

November 1, 2019

Enrollment Period

4 months

First QC Date

June 29, 2018

Results QC Date

September 27, 2019

Last Update Submit

November 13, 2019

Conditions

Keywords

tobaccosmokingcigarette

Outcome Measures

Primary Outcomes (2)

  • Self-reported Serious Quit Attempt Measured Via the 'Quitting Preparation and Actions Questionnaire'

    A self-described "serious" attempt to quit smoking cigarettes since the initial study appointment, measured by the "Quitting Preparation and Actions Questionnaire."

    30 days

  • Self-reported Treatment Seeking Measured Via the 'Quitting Preparation and Actions Questionnaire'

    Self-reported contact with one of two treatment referrals provided at intervention since the time of the initial study appointment

    30 days

Secondary Outcomes (3)

  • Self-reported Cigarettes Per Day

    30 days

  • Importance, Confidence, & Readiness Questionnaire

    30 days

  • Readiness to Quit Ladder

    30 days

Study Arms (3)

Motivational Interviewing

EXPERIMENTAL

35 minute individual motivational interviewing intervention concluding with a written referral sheet for a local smoking cessation clinic and the New Jersey State Quit Line

Behavioral: Motivational Interviewing

Nicotine Replacement Therapy Sampling

ACTIVE COMPARATOR

Participants are provided with a 2-week supply of nicotine patches and a 2 week supply of nicotine lozenges with a recommendation to try them and are also given a written referral sheet for a local smoking cessation clinic and the New Jersey State Quit Line.

Drug: Nicotine Replacement Therapy Sampling

Referral Only

OTHER

Participants are provided with a written referral sheet for a local smoking cessation clinic and the New Jersey State Quit Line.

Behavioral: Referral Only

Interventions

Participants are provided with a 35 minute counseling session designed to increase motivation to quit smoking and then provided with a written referral for tobacco dependence treatment.

Motivational Interviewing

Participants are provided with a two-week sample of over-the-counter nicotine replacement therapy (i.e., nicotine lozenge and nicotine patch) and then provided with a written referral for tobacco dependence treatment.

Also known as: Nicotine Replacement Therapy
Nicotine Replacement Therapy Sampling
Referral OnlyBEHAVIORAL

Participants are provided with a written referral for tobacco dependence treatment.

Also known as: Referral
Referral Only

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants must be between the age of 19 and 65
  • Participants must self-report being a daily smoker and provide biochemical verification of smoking status (expired breath carbon monoxide reading \>5)
  • Participants must be at socioeconomic disadvantage, defined as receiving services at a New Brunswick, New Jersey based social services agency (i.e., living in New Brunswick Housing Authority-run public housing units or requesting social services from the community social service agency, "Elijah's Promise")
  • Participants must be able to speak and read English.

You may not qualify if:

  • Participants may not be taking FDA approved smoking cessation or anti-psychotic medications
  • Participants may not reported medical issues of potential concern to nicotine replacement users (e.g., unstable angina pectoris, myocardial infarction, or significant cardiac arrythmia (including atrial fibrillation) in the past 30 days)
  • Participants may not report pending legal issues with potential to result in incarceration.
  • Participants may not be pregnant or nursing, planning on becoming pregnant in the next two months, and must be using effective birth control.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Division of Addiction Psychiatry

New Brunswick, New Jersey, 08901, United States

Location

MeSH Terms

Conditions

Tobacco SmokingSmoking

Interventions

Motivational InterviewingNicotine Replacement TherapyReferral and Consultation

Condition Hierarchy (Ancestors)

BehaviorTobacco Use

Intervention Hierarchy (Ancestors)

Directive CounselingCounselingMental Health ServicesBehavioral Disciplines and ActivitiesHealth ServicesHealth Care Facilities Workforce and ServicesDrug TherapyTherapeuticsProfessional PracticeOrganization and AdministrationHealth Services Administration

Results Point of Contact

Title
Marc L. Steinberg, Ph.D.
Organization
Rutgers Robert Wood Johnson Medical School

Study Officials

  • Marc L Steinberg, Ph.D.

    Rutgers Robert Wood Johnson Medical School

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The individual conducting the outcomes assessment is blind to study condition.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized clinical trial in which participants are randomized to one of three groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 29, 2018

First Posted

August 8, 2018

Study Start

May 30, 2018

Primary Completion

October 1, 2018

Study Completion

October 1, 2018

Last Updated

November 15, 2019

Results First Posted

November 15, 2019

Record last verified: 2019-11

Data Sharing

IPD Sharing
Will not share

Locations